Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Grail Inc (GRAL)

Grail Inc (GRAL)
33.76 x 8 34.40 x 4
Post-market by (Cboe BZX)
33.76 +4.07 (+13.71%) 04/23/25 [NASDAQ]
33.76 x 8 34.40 x 4
Post-market 33.76 unch (unch) 19:09 ET
Quote Overview for Wed, Apr 23rd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
32.48
Day High
36.07
Open 32.48
Previous Close 29.69 29.69
Volume 1,987,100 1,987,100
Avg Vol 1,223,250 1,223,250
Stochastic %K 87.53% 87.53%
Weighted Alpha +13.43 +13.43
5-Day Change +7.82 (+30.17%) +7.82 (+30.17%)
52-Week Range 12.33 - 63.99 12.33 - 63.99
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,047,968
  • Shares Outstanding, K 35,297
  • Annual Sales, $ 125,600 K
  • Annual Income, $ -2,027 M
  • EBIT $ -598 M
  • EBITDA $ 808 M
  • 60-Month Beta N/A
  • Price/Sales 7.43
  • Price/Cash Flow 0.92
  • Price/Book 0.35

Options Overview Details

View History
  • Implied Volatility 117.74% ( +1.51%)
  • Historical Volatility 116.53%
  • IV Percentile 93%
  • IV Rank 58.87%
  • IV High 161.34% on 02/14/25
  • IV Low 55.34% on 11/26/24
  • Put/Call Vol Ratio 0.30
  • Today's Volume 3,053
  • Volume Avg (30-Day) 1,330
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 19,040
  • Open Int (30-Day) 18,273

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -4.03
  • Number of Estimates 1
  • High Estimate -4.03
  • Low Estimate -4.03
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.40%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.44 +65.17%
on 04/07/25
Period Open: 30.29
36.19 -6.71%
on 04/23/25
+3.47 (+11.46%)
since 03/21/25
3-Month
20.44 +65.17%
on 04/07/25
Period Open: 25.97
63.99 -47.24%
on 02/18/25
+7.79 (+30.00%)
since 01/23/25

Most Recent Stories

More News
Investors Eye Biotech Sector as Cancer Therapy Market Surges

/CNW/ -- USA News Group News Commentary – Amid the excitement surrounding Project Stargate—the $500 billion investment aimed at revolutionizing AI-driven data...

ONCY : 0.5666 (-5.57%)
RENB : 0.3756 (+7.87%)
POAI : 0.9573 (+7.28%)
DGX : 173.57 (+0.42%)
GRAL : 33.76 (+13.71%)
ONC.TO : 0.79 (-5.95%)
Top 5 Biotech Stocks That Got Most Retail Buzz Last Week

From merger updates to earnings surprises, these healthcare stocks saw the biggest spike in Stocktwits chatter.

GRAL : 33.76 (+13.71%)
ADMA : 21.73 (+1.59%)
EXEL : 36.78 (+0.82%)
GLYC : 0.2387 (+5.39%)
MBRX : 1.0300 (-1.90%)
Stock Market News for Feb 6, 2025

U.S. stock markets closed higher on Wednesday posting back-to-back closing in green. Market participants regained confidence on risky assets like equities as global trade war related concerns reduced to...

GRAL : 33.76 (+13.71%)
Oncology Experts Predict 2025 Will Be a Year of Breakthroughs in Treatment and Prevention

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – One of the largest and most advanced cancer research and treatment organizations in the USA, City of Hope,...

ONCY : 0.5666 (-5.57%)
GH : 45.64 (+4.20%)
LEGN : 34.30 (-0.52%)
PSNL : 3.68 (+7.92%)
GRAL : 33.76 (+13.71%)
ONC.TO : 0.79 (-5.95%)
GRAIL: Biotech Stock Targeting $100B Cancer Market

GRAIL is a small biotech stock on the rise big time recently. Its innovative technology gives it the opportunity to capitalize on a massive addressable market.

ILMN : 76.25 (+2.56%)
MS : 112.31 (+1.75%)
GRAL : 33.76 (+13.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

GRAIL LLC is a biotechnology company. It focuses on developing technologies for early cancer detection. GRAIL LLC is based in Menlo Park, United States.

See More

Key Turning Points

3rd Resistance Point 39.97
2nd Resistance Point 38.08
1st Resistance Point 35.92
Last Price 33.76
1st Support Level 31.87
2nd Support Level 29.98
3rd Support Level 27.82

See More

52-Week High 63.99
Fibonacci 61.8% 44.26
Fibonacci 50% 38.16
Last Price 33.76
Fibonacci 38.2% 32.06
52-Week Low 12.33

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective